Detalhe da pesquisa
1.
Correction: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.
J Transl Med
; 22(1): 296, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38515188
2.
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Cancer Immunol Immunother
; 58(7): 1023-32, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19002459
3.
yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.
J Transl Med
; 7: 92, 2009 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900287
4.
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
Clin Cancer Res
; 14(24): 8228-35, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19088040
5.
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Clin Cancer Res
; 14(16): 5166-72, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18698034
6.
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clin Cancer Res
; 14(18): 5759-68, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18794085
7.
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Clin Neurosurg
; 56: 98-106, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20214040